596 results on '"Corpechot, Christophe"'
Search Results
2. Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.
3. Dynamics of Liver Stiffness Measurement and Clinical Course of Primary Biliary Cholangitis
4. Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitis
5. Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantation
6. Type of calcineurin inhibitor and long-term outcomes following liver transplantation in patients with primary biliary cholangitis – an ELTR study
7. The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial
8. Protective potential of the gallbladder in primary sclerosing cholangitis
9. Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis
10. Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis
11. Noninvasive Evaluation of Fibrosis and Portal Hypertension in Primary Biliary Cholangitis
12. ABCB4 variant is associated with hepatobiliary MR abnormalities in people with low-phospholipid-associated cholelithiasis syndrome
13. Quantitative magnetic resonance cholangiopancreatography metrics are associated with disease severity and outcomes in people with primary sclerosing cholangitis
14. Low Phospholipid-Associated Cholelithiasis (LPAC)
15. Non-invasive diagnosis and follow-up in liver transplantation
16. Non-invasive diagnosis and follow-up of primary biliary cholangitis
17. Recurrence of autoimmune liver diseases after liver transplantation: Review and expert opinion statement
18. THU-107 Short- and medium-term effects of hypnosis and psychoeducational interventions on fatigue associated with primary biliary cholangitis: a randomized controlled trial
19. LBP-040 Long-term efficacy and safety of open-label seladelpar treatment in patients with primary biliary cholangitis (PBC): interimresults for 2 years from the ASSURE study
20. LBP-027 Combined effect of obeticholic acid and bezafibrate in patients with primary biliary cholangitis and inadequate response or intolerance to ursodeoxycholic acid: 6-month results from a phase 2 trial
21. THU-125 Key questions that patients with primary biliary cholangitis should ask their physician -Delphi method-
22. THU-102-YI Specific glycomic profiles can identify patients at risk of poor transplant-free survival in primary biliary cholangitis
23. GS-007 Prospective validation of the prognostic value of liver stiffness assessed by Fibroscan in primary sclerosing cholangitis: final results of the FICUS study
24. THU-111 Second-line treatment in recurrent primary biliary cholangitis after liver transplantation: an international multicentre study
25. LBP-006 Efficacy of elafibranor in primary biliary cholangitis: results from the variable double-blind period of ELATIVE®, a randomised, placebo-controlled phase III trial
26. THU-098 Appraising gain of an extended 2-year placebo-controlled trial in primary biliary cholangitis: challenges for evaluating clinical outcomes
27. THU-136 The epidemiological and prognostic burden of autoimmune liver disease: results of a nationwide population-based study over the past decade
28. Type of calcineurin inhibitor and long-term outcomes following liver transplantation in patients with Primary Biliary Cholangitis- an ELTR study
29. PPAR agonists in PBC: Where do we go from here? Or how to choose between the new and the old.
30. Fibrosis and Prognosis Assessment Using Liver Stiffness in Patients with PBC and PSC
31. Definition and Management of Patients With Primary Biliary Cholangitis and an Incomplete Response to Therapy
32. Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe
33. Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis
34. Low-phospholipid-associated cholelithiasis syndrome: Prevalence, clinical features, and comorbidities
35. Type of calcineurin inhibitor and long-term outcomes following liver transplantation in patients with primary biliary cholangitis – an ELTR study
36. Factors Associated With Progression and Outcomes of Early Stage Primary Biliary Cholangitis
37. Exploring the impact of ursodeoxycholic acid therapy on COVID‐19 in a real‐world setting
38. Simple Magnetic Resonance Scores Associate With Outcomes of Patients With Primary Sclerosing Cholangitis
39. Rate of Spleen Length Progression Is a Marker of Outcome in Patients With Primary Sclerosing Cholangitis
40. New treatments/targets for primary biliary cholangitis
41. Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis
42. Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis
43. Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy Individuals
44. Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival
45. Autoimmune hepatitis recurrence after liver transplantation: “Les jeux sont faits”.
46. Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool
47. Management of primary biliary cholangitis: results from a large real-life observational study in France and Belgium
48. Reply: Improving access to transient elastography data for Real-World Prognostic Applications in primary biliary cholangitis
49. Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis
50. Obeticholic acid as a second‐line treatment for low phospholipid‐associated cholelithiasis syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.